CCL2 and breast carcinoma: Breast cancer patients with high CCL2 expression in their tumor cells possessed a shorter RFS [27], and for clear cell renal cell cancer patients, elevated CCL2 expression was correlated with clinical stage, OS, and macrophage infiltration [32].